Treatment Action Group, a TB Alliance stakeholder organization, today released preliminary results from its survey of major funders of TB research and development.
The study seeks to ascertain major R&D funders in 2005, the last year for which relatively complete data is available. It includes an assessment of existing research activities, and information on the variety of newly funded work.